124 related articles for article (PubMed ID: 26313376)
1. Cirrhosis and dysbiosis: New insights from next-generation sequencing.
Gorham J; Gleeson M
Hepatology; 2016 Jan; 63(1):336-8. PubMed ID: 26313376
[No Abstract] [Full Text] [Related]
2. Decompensated cirrhosis and microbiome interpretation.
Bajaj JS; Betrapally NS; Gillevet PM
Nature; 2015 Sep; 525(7569):E1-2. PubMed ID: 26381988
[No Abstract] [Full Text] [Related]
3. Qin et al. reply.
Qin N; Le Chatelier E; Guo J; Prifti E; Li L; Ehrlich SD
Nature; 2015 Sep; 525(7569):E2-3. PubMed ID: 26381989
[No Abstract] [Full Text] [Related]
4. Alterations of the human gut microbiome in liver cirrhosis.
Qin N; Yang F; Li A; Prifti E; Chen Y; Shao L; Guo J; Le Chatelier E; Yao J; Wu L; Zhou J; Ni S; Liu L; Pons N; Batto JM; Kennedy SP; Leonard P; Yuan C; Ding W; Chen Y; Hu X; Zheng B; Qian G; Xu W; Ehrlich SD; Zheng S; Li L
Nature; 2014 Sep; 513(7516):59-64. PubMed ID: 25079328
[TBL] [Abstract][Full Text] [Related]
5. Association of Enteric Protist Blastocystis spp. and Gut Microbiota with Hepatic Encephalopathy.
Yildiz S; Doğan İ; Doğruman-Al F; Nalbantoğlu U; Üstek D; Sarzhanov F; Yildirim S
J Gastrointestin Liver Dis; 2016 Dec; 25(4):489-497. PubMed ID: 27981305
[TBL] [Abstract][Full Text] [Related]
6. The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma.
Roderburg C; Luedde T
Gut Microbes; 2014 Jul; 5(4):441-5. PubMed ID: 25006881
[TBL] [Abstract][Full Text] [Related]
7. Growth dynamics of gut microbiota in health and disease inferred from single metagenomic samples.
Korem T; Zeevi D; Suez J; Weinberger A; Avnit-Sagi T; Pompan-Lotan M; Matot E; Jona G; Harmelin A; Cohen N; Sirota-Madi A; Thaiss CA; Pevsner-Fischer M; Sorek R; Xavier R; Elinav E; Segal E
Science; 2015 Sep; 349(6252):1101-1106. PubMed ID: 26229116
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota and the development of pediatric diseases.
Lu CY; Ni YH
J Gastroenterol; 2015 Jul; 50(7):720-6. PubMed ID: 25917564
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathophysiological consequences of alterations in the microbiome in cirrhosis.
Macnaughtan J; Jalan R
Am J Gastroenterol; 2015 Oct; 110(10):1399-410; quiz 1411. PubMed ID: 26416191
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota of Nonalcoholic Fatty Liver Disease.
Abdou RM; Zhu L; Baker RD; Baker SS
Dig Dis Sci; 2016 May; 61(5):1268-81. PubMed ID: 26898658
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
12. The Microbiome and Risk for Atherosclerosis.
Komaroff AL
JAMA; 2018 Jun; 319(23):2381-2382. PubMed ID: 29800043
[No Abstract] [Full Text] [Related]
13. [A clinical analysis of digestive tract fungus infection in patients with liver cirrhosis].
Dai M
Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):460-1. PubMed ID: 17594815
[No Abstract] [Full Text] [Related]
14. The bacterial skin microbiome in psoriatic arthritis, an unexplored link in pathogenesis: challenges and opportunities offered by recent technological advances.
Castelino M; Eyre S; Upton M; Ho P; Barton A
Rheumatology (Oxford); 2014 May; 53(5):777-84. PubMed ID: 24067887
[TBL] [Abstract][Full Text] [Related]
15. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?
Belcheva A; Irrazabal T; Martin A
Bioessays; 2015 Apr; 37(4):403-12. PubMed ID: 25601287
[TBL] [Abstract][Full Text] [Related]
16. The human gut microbiome impacts health and disease.
Ehrlich SD
C R Biol; 2016; 339(7-8):319-23. PubMed ID: 27236827
[TBL] [Abstract][Full Text] [Related]
17. Analysis of gut microbiota - An ever changing landscape.
Sadowsky MJ; Staley C; Heiner C; Hall R; Kelly CR; Brandt L; Khoruts A
Gut Microbes; 2017 May; 8(3):268-275. PubMed ID: 28051919
[TBL] [Abstract][Full Text] [Related]
18. Application of metagenomics in the human gut microbiome.
Wang WL; Xu SY; Ren ZG; Tao L; Jiang JW; Zheng SS
World J Gastroenterol; 2015 Jan; 21(3):803-14. PubMed ID: 25624713
[TBL] [Abstract][Full Text] [Related]
19. HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.
Bajaj JS; Sterling RK; Betrapally NS; Nixon DE; Fuchs M; Daita K; Heuman DM; Sikaroodi M; Hylemon PB; White MB; Ganapathy D; Gillevet PM
Aliment Pharmacol Ther; 2016 Sep; 44(6):638-43. PubMed ID: 27417456
[TBL] [Abstract][Full Text] [Related]
20. Colonization with the enteric protozoa Blastocystis is associated with increased diversity of human gut bacterial microbiota.
Audebert C; Even G; Cian A; ; Loywick A; Merlin S; Viscogliosi E; Chabé M
Sci Rep; 2016 May; 6():25255. PubMed ID: 27147260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
